overcoming resistance to car-t: target upregulation, microenvironment modulation, and novel targets
Published 2 years ago • 53 plays • Length 3:07Download video MP4
Download video MP3
Similar videos
-
2:43
mechanisms of resistance to car-t therapy in lymphoma & potential strategies to overcome these
-
3:38
mechanisms of resistance to car-t in all: t-cell fitness, antigen loss and immunological rejection
-
1:35
key mechanisms of resistance to car t-cell therapy
-
1:57
tackling resistance to car-t in all
-
4:23
novel strategies to optimize car t-cell therapy
-
1:59
the limitations of car-t currently: overcoming resistance
-
1:13
overcoming car-t resistance in cll: combining with ibrutinib
-
2:43
resistance to car t-cell therapy
-
2:17
overcoming resistance to car-t therapy in cll with ibrutinib & venetoclax
-
1:41
risk stratifying patients with the car-hematotox score to improve outcomes after car-t
-
3:01
strategies to optimize the outcomes of earlier-line patients treated with car t-cell therapy
-
2:10
managing hematologic toxicity associated with car-t therapy & insights into the car-hematotox score
-
5:43
strategies to overcome the current obstacles in car-t manufacturing
-
1:51
regulatory and commercialization challenges with car t-cell therapy
-
4:16
the challenges with car t-cell therapy for t-all and the progress made to overcome these challenges
-
1:05
overcoming t-cell exhaustion to improve car-t efficacy in multiple myeloma
-
1:42
challenges associated with car-t cell production
-
3:17
tcxpress™ vs car-t therapy & targeting leukemia with tcr t-cells
-
0:43
developing an avidcar platform to improve t-cell activity